Sign in
4

Changes in Ownership

Larimar Therapeutics, Inc. Filed Acc 0001062993-25-009379

Options or other derivatives

  • Director acquired 19,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Truitt Joseph Director 2025-05-13 Grant or award · Stock Option (Right to Buy) +19,000 19,000 D: show line 1 in the form
Loading xslF345X05/form4.xml…